Who owns STANDARD BIOTOOLS INC. (FLDM)? Elite investor 13F holders
3 tracked elite investors reported holding STANDARD BIOTOOLS INC as of 2026-06-30, including Viking Global Investors, D.E. Shaw, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments,…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Viking Global Investors | Fluidigm Corp | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 48252318.00 USD | 58651170.000000 | Shares | hold | Original filing |
| D.E. Shaw | Fluidigm Corp | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2318390.00 USD | 2818026.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | Fluidigm Corp | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 816166.00 USD | 992058.000000 | Shares | buy | Original filing |
| Corvex Management | Fluidigm Corp | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.